Infliximab and adalimumab (anti-TNF)
The first biologics for IBD, and still among the most effective, especially for fistulising Crohn’s. Infliximab is a drip; adalimumab is a self-injection.
Quick answer: Anti-TNF drugs block tumour necrosis factor, a key driver of gut inflammation. They induce and maintain remission, heal the bowel lining and fistulas, and reduce surgery. Biosimilars (cheaper copies) work the same. The body can make antibodies against them, so drug levels are sometimes checked.
At a glance
- For
- Moderate to severe Crohn’s disease (including fistulas) and ulcerative colitis
- Works
- Remission in roughly a third to half at a year; best early in disease
- Cost
- PBS-subsidised for moderate to severe IBD under specialist (gastroenterologist) criteria
- Kicks in
- 2 to 8 weeks
- Dose
- Infliximab: IV at weeks 0, 2, 6, then every 8 weeks (or under-skin injections). Adalimumab: injection every 1 to 2 weeks
- Watch for
- Infections, infusion or injection reactions
The original gut firefighter.
Brand names
- Infliximab: Remicade, Inflectra, Renflexis, Remsima (incl. under-skin form). Adalimumab: Humira, Hadlima, Hyrimoz, Amgevita, Yuflyma. Golimumab (Simponi) for colitis
How it works
They bind TNF-alpha, switching off a central inflammatory pathway.
Used for
- Moderate to severe Crohn’s disease, including perianal fistulas
- Moderate to severe ulcerative colitis
- Also rheumatoid arthritis, psoriasis, ankylosing spondylitis and uveitis
Side effects
Infection risk is the main concern.
Full side-effect list (from the product information)
How often, from the official product information. Bold = serious.
Common 1 in 10 to 1 in 100
- Infections (colds, sinus, chest, urine)
- Infusion or injection-site reactions
- Headache
Uncommon 1 in 100 to 1 in 1,000
- Psoriasis-like rashes (paradoxical)
- Abnormal liver tests
Rare 1 in 1,000 to 1 in 10,000
- TB reactivation and serious infections
- Lymphoma (mainly with thiopurine combination)
- Demyelination, drug-induced lupus, heart failure worsening
Get help urgently if
- Fever, night sweats, persistent cough or weight loss
- Shortness of breath or swelling in heart failure
- Numbness, weakness or vision changes
Good to know
- Before starting: screening for tuberculosis, hepatitis B and C and HIV, and catch-up vaccines.
- Avoid live vaccines (e.g. yellow fever, some shingles and travel vaccines) unless your specialist says otherwise.
- Tell your doctors before surgery, and if you get a fever or infection.
- Most biologics can be continued in pregnancy after discussion with your gastroenterologist.
- Combining infliximab with azathioprine reduces antibodies and improves response.
Common questions
What is the difference between infliximab and adalimumab?
Both block TNF. Infliximab is usually an IV infusion every 8 weeks (an under-skin form now exists); adalimumab is a self-injection every 1 to 2 weeks.
Are biosimilars as good as the original?
Yes. Biosimilars are approved as equivalent and are widely used in Australia.
Why are drug levels checked?
Low levels or antibodies can explain loss of response, guiding a dose change or switch.
Information only. Not a recommendation or endorsement of any product. Whether a medicine suits you depends on your health and other medicines, so talk to your doctor or pharmacist. In an emergency, call 000 (Australia) or your local emergency number. From a mobile, 112 works in most countries.
More information
maladywise.com/medicines/anti-tnf-biologics/